Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.b.32510DOI Listing

Publication Analysis

Top Keywords

discovery lrrk2
4
lrrk2 pr1441s
4
pr1441s novel
4
novel mutation
4
mutation parkinson's
4
parkinson's disease
4
disease adds
4
adds complexity
4
complexity mutational
4
mutational hotspot
4

Similar Publications

Social isolation is an established risk factor for psychiatric illness, and became increasingly topical with the spread of SARS-CoV-2. We used RNA sequencing (RNA-Seq) to enable unbiased assessment of transcriptomic changes within the prefrontal cortex (PFC) of isolation-reared rats. To provide insight into the relevance of this manipulation for studying human illness, we compared differentially expressed genes (DEGs) and enriched biological functions against datasets involving post-mortem frontal cortical tissue from patients with psychiatric and neurodevelopmental illnesses.

View Article and Find Full Text PDF

The CACHE challenges are a series of prospective benchmarking exercises to evaluate progress in the field of computational hit-finding. Here we report the results of the inaugural CACHE challenge in which 23 computational teams each selected up to 100 commercially available compounds that they predicted would bind to the WDR domain of the Parkinson's disease target LRRK2, a domain with no known ligand and only an apo structure in the PDB. The lack of known binding data and presumably low druggability of the target is a challenge to computational hit finding methods.

View Article and Find Full Text PDF

Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder. However, current treatments are directed at symptoms and lack ability to slow or prevent disease progression. Large-scale genome-wide association studies (GWAS) have identified numerous genomic loci associated with PD, which may guide the development of disease-modifying treatments.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers created a machine learning tool called ML-GPS to help find genetic factors linked to chronic diseases, aiding in drug development.
  • This tool combines genetic data from the UK Biobank with advanced modeling techniques to predict disease phenotypes and their associations with various genetic variants.
  • ML-GPS significantly increases the number of potential drug targets and can identify both established and promising target-disease relationships, including those related to Parkinson's and cardiovascular diseases.
View Article and Find Full Text PDF

Designing the First Trials for Parkinson's Prevention.

J Parkinsons Dis

October 2024

Molecular Neurobiology Laboratory, MassGeneral Institute for Neurodegenerative Disease, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, USA.

For decades the greatest goal of Parkinson's disease (PD) research has often been distilled to the discovery of treatments that prevent the disease or its progression. However, until recently only the latter has been realistically pursued through randomized clinical trials of candidate disease-modifying therapy (DMT) conducted on individuals after they received traditional clinical diagnosis of PD (i.e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!